Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies

Cited by papers we hold 7

• Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice · 2021
  No notice
• The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health · 2021
  No notice
• Gut Microbiota in Hypertension and Atherosclerosis: A Review · 2020
  No notice
• Implication of Gut Microbiota in Cardiovascular Diseases · 2020
  No notice
• Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease · 2019
  No notice
• Precision Nutrition and the Microbiome, Part I: Current State of the Science · 2019
  No notice
• Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.